Sector: Pharmaceuticals & Biotechnology

Large Cap

Divi's Laboratories Share Price

DIVISLAB

₹6,830.50

17.50(0.26%)

10th Jul 2026 | 3:28 PM

NSE : DIVISLAB

Open Free Demat Account

Divi's Laboratories Performance

Price Movement

₹6830.50

₹6775.00

₹6871.50

↘ Today's Low↗ Today's High

1 Year Performance

₹6830.50

₹5636.50

₹7009.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹6,871.50

Low₹6,775.00

Open at₹6,870.00

Prev Close₹6,813.00

Volumes2.23 L

Avg Price₹6,822.38

Lower Circuit₹6,132.00

Upper Circuit₹7,494.00

Historical Performance

3M High₹6,968.00

3M Low₹5,931.00

1 Yr High₹6,982.50

1 Yr Low₹5,636.50

3 Yr High₹7,071.50

3 Yr Low₹3,295.30

5 Yr High₹7,071.50

5 Yr Low₹2,730.00

Summary

As of 10-07-2026 07:50, Divi's Laboratories Ltd. share price today is ₹0, with a change of ₹-6813.00 (-100.00%) from the previous close of ₹6813. The stock opened at ₹6870 and traded between ₹6775 and ₹6871.5, with a total traded volume of 222860 shares. The company has a market capitalization of ₹180863.8 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹7009.5 and ₹5636.5, respectively.

Divi's Laboratories Ltd. valuation metrics include a P/E ratio of 70.4, EPS of ₹96.75, and book value of ₹10.80. Profitability indicators show ROE of 15.32% along with a dividend yield of 0.4%. Divi's Laboratories Ltd. has reported revenue of ₹10560 Cr and net profit of ₹2568 Cr.

Divi's Laboratories Ltd. technical indicators include Day RSI at 56.74, Day MFI at 47.61, Day ADX at 24.4. Additional indicators include Commodity Channel Index (CCI) at 116.1 and Williams %R at -34.07. Momentum indicators show Day MACD at 32.47, Day MACD Signal Line at 21.66, DayATR at 149.49. Rate of Change indicators for Divi's Laboratories Ltd. include ROC125 at 6.58 and ROC21 at 0.89.

Exponential moving averages include EMA5 at ₹6771.2, EMA10 at ₹6740.8, EMA12 at ₹6733.4, EMA20 at ₹6714, EMA26 at ₹6700.9, EMA50 at ₹6634.8, EMA100 at ₹6526.3, EMA200 at ₹6401.6. Simple moving averages include SMA5 at ₹6790.8, SMA10 at ₹6703.2, SMA20 at ₹6705.4, SMA30 at ₹6678.9, SMA50 at ₹6699, SMA100 at ₹6443.2, SMA150 at ₹6399.6, SMA200 at ₹6389.5.

Support levels for Divi's Laboratories are placed at First Support ₹6720.67, Second Support ₹6628.33, Third Support ₹6516.17. Resistance levels are seen at First Resistance ₹6925.17, Second Resistance ₹7037.33, Third Resistance ₹7129.67. Divi's Laboratories Ltd. shareholding pattern shows promoter holding at 51.88%, FII holding at 20.29%, DII holding at 0%, public holding at 8.61%.

Divi's Laboratories Fundamentals

Market Cap

Market Runner Up

1,80,863.80 Cr.

PE Ratio (TTM)

High in industry

70.40

Dividend Yield

Below industry Median

0.40

Net Profit TTM

17.2% incr over last year

2,568

Net Profit Growth

17.2% incr over last year

2,568

PEG Ratio

High in industry

4.10

ROE

4.7% incr over last year

15.32

Operating Revenue TTM

10,560

Operating Revenue Growth

12.8% incr over last year

Book Value

High in industry

10.80

MFI

MFI is mid-range

47.61

RSI

RSI is mid-range

56.74

EPS (TTM)

96.75

Debt to Equity

Face Value

Operating Profit Margin Qtr.

31.09

Operating Profit Qtr.

934

Net Profit Qtr.

751

Operating Revenue Qtr.

2,831

PB Ratio

10.80

Divi's Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	2,793	2,578	2,660	2,357	2,536
Operating Expense	1,850	1,671	1,765	1,614	1,655
Operating Profit	943	907	895	743	881
Depreciation	120	116	113	112	107
Interest	6	6	8	3	0
Tax	215	200	224	190	194
Net Profit	756	598	696	557	667

DIVISLAB Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

₹6,363 - ₹0

Target Price

₹7,870

Stop Loss

Target Date

27 May 27

Potential Returns

23.68 %

View Call ↗

Divi's Laboratories Technicals

Divi's Laboratories Ltd. EMA & SMA

₹6830.50

75.50 (1.12%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹6771.2

Day EMA10 ₹6740.8

Day EMA12 ₹6733.4

Day EMA20 ₹6714

Day EMA26 ₹6700.9

Day EMA50 ₹6634.8

Day EMA100 ₹6526.3

Day EMA200 ₹6401.6

Divi's Laboratories Support and Resistance

Resistance

First Resistance₹6925.17

Second Resistance₹7037.33

Third Resistance₹7129.67

Support

First Support₹6720.67

Second Support₹6628.33

Third Support₹6516.17

Technical Indicators

Day RSI56.74

Day MFI47.61

Day ADX24.40

Day Commodity Channel Index116.10

William-34.07

Day MACD32.47

Day MACD Signal Line21.66

Day ATR149.49

Day ROC1256.58

Day ROC210.89

Divi's Laboratories Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	51.9	51.9	51.9	51.9	51.9	51.9
FII	18	18	19.7	19.4	20.1	20.3
DII	20.5	20.7	19.1	19.8	19.3	19.2
Public	9.6	9.4	9.3	9	8.8	8.6

Divi's Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.98 L	3.69 L	53.75%
Week	2.68 L	4.33 L	61.76%
1 Month	2.18 L	3.61 L	60.28%
6 Month	2.15 L	3.72 L	57.86%

Divi's Laboratories SWOT Analysis

Strengths23

Weakness8

Opportunity7

Threats1

Companies with no Debt

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Expensive Stars (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Annual Profit Growth higher than Sector Profit Growth

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Negative to Positive growth in Sales and Profit with Strong Price momentum

RSI indicating price strength

Top Gainers

Stocks near 52 Week High with Significant Volumes

Divi's Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
24 Jul, 2026	30	FINAL	24 Jul, 2026	Equity Share
25 Jul, 2025	30	FINAL	25 Jul, 2025	Equity Share
02 Aug, 2024	30	FINAL	02 Aug, 2024	Equity Share
11 Aug, 2023	30	FINAL	11 Aug, 2023	Equity Share
11 Aug, 2022	30	FINAL	12 Aug, 2022	Equity Share
17 Aug, 2021	20	FINAL		Equity Share
25 Feb, 2020	16	INTERIM	26 Feb, 2020	Equity Share
14 Aug, 2019	16	FINAL		Equity Share
31 Aug, 2018	10	FINAL		Equity Share
15 Sep, 2017	10	FINAL		Equity Share

Divi's Laboratories Stock Comparison

Financials	Rubicon Research Ltd.	Anthem Biosciences Ltd.	Sai Life Science Ltd.	Emcure Pharmaceuticals Ltd.	Mankind Pharma Ltd.	Piramal Pharma Ltd.
Price (₹)	₹1,429	₹754.95	₹1,265	₹1,805	₹2,523	₹176.50
% Change	1.55%	0.39%	2.48%	-0.25%	-0.36%	2.62%
Revenue TTM (₹ Cr)	₹1,753.96	₹2,124.33	₹2,192.49	₹9,203.54	₹14,277.64	₹8,869.07
Net Profit TTM (₹ Cr)	₹246.74	₹591.79	₹348.91	₹924.36	₹1,912.93	₹-325.93
PE TTM	94.30	71.60	75.10	37.10	54.70	-70.30
1 Year Return	190.14	31.93	57.98	43.82	0.21	-14.62
ROCE	24.32	27.56	18.38	25.65	14.32	2.29

Similar Stocks

ACUTAAS

Acutaas Chemicals Ltd.

₹ 3390.00

-1.99%

GLAND

Gland Pharma Ltd.

₹ 2475.00

+0.22%

LAURUSLABS

Laurus Labs Ltd.

₹ 1535.50

+1.86%

ALKEM

Alkem Laboratories Ltd.

₹ 5676.00

+0.49%

BIOCON

Biocon Ltd.

₹ 418.25

+3.64%

GRANULES

Granules India Ltd.

₹ 887.00

+0.56%

AJANTPHARM

Ajanta Pharma Ltd.

₹ 3366.00

+1.77%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 1152.10

-0.60%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2284.50

+0.76%

WOCKPHARMA

Wockhardt Ltd.

₹ 1812.80

-1.01%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1568.90

-1.17%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1932.90

-0.30%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 19478.00

-0.33%

IPCALAB

Ipca Laboratories Ltd.

₹ 1780.10

+0.55%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2420.00

-1.00%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8115.00

+0.01%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2433.00

-0.30%

PFIZER

Pfizer Ltd.

₹ 4720.00

+2.83%

ABBOTINDIA

Abbott India Ltd.

₹ 27340.00

+2.13%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4890.00

-0.17%

LUPIN

Lupin Ltd.

₹ 2496.00

-0.29%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1246.90

-1.78%

CIPLA

Cipla Ltd.

₹ 1442.00

+0.05%

FAQ's on DIVISLAB

What is the current share price of Divi's Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Divi's Laboratories Ltd. is ₹ 6830.5 on the NSE and ₹ 6832.3 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Divi's Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Divi's Laboratories Ltd. is approximately ₹ 180863.8 Cr.

What are the PE and PB ratios for Divi's Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Divi's Laboratories Ltd. is 70.4, and the Price-to-Book (PB) ratio is 10.8.

What is the 52-Week High and Low for Divi's Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Divi's Laboratories Ltd. shares was ₹ 6982.5, and the lowest price was ₹ 5636.5.

What is the current dividend yield for Divi's Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Divi's Laboratories Ltd. is 0.4%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Divi's Laboratories Ltd.?

Significant shareholdings in Divi's Laboratories Ltd. typically include entities such as:

Promoter
FII
Mutual Funds
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Divi's Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Divi's Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Divi's Laboratories Ltd.?

Divi's Laboratories Ltd. last declared a FINAL dividend of ₹ 30 per share for the financial period ending 2026. The record date was set as 2026-07-24, and the payment was/is scheduled around 2026-07-24. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy